|1.||Xie, Ping: 7 articles (01/2015 - 11/2004)|
|2.||Bishop, Gail A: 5 articles (09/2015 - 11/2004)|
|3.||Liu, Yan: 5 articles (01/2015 - 01/2011)|
|4.||Shu, Hong-Bing: 4 articles (09/2015 - 12/2002)|
|5.||Moore, Carissa R: 4 articles (01/2015 - 01/2013)|
|6.||Li, Hongliang: 3 articles (01/2016 - 08/2015)|
|7.||Zhang, Xiao-Fei: 3 articles (01/2016 - 08/2015)|
|8.||Gao, Lu: 3 articles (01/2016 - 08/2015)|
|9.||Zhang, Peng: 3 articles (01/2016 - 08/2015)|
|10.||Zhao, Guang-Nian: 3 articles (01/2016 - 08/2015)|
02/05/2015 - "Overall, 30% of the tumors contained ≥1 somatic TRAF3 mutation. "
02/05/2015 - "We found mutations affecting TRAF3, which encodes a negative regulator of nuclear factor (NF)-κB, to be a common feature of cBCLs, with mutations observed in 44% of tumors including a combination of somatic and rare germ-line variants. "
01/01/2014 - "These results provide further insight into the role of TRAF3 and NIK in T cell malignancies and indicate that TRAF3 differentially governs the growth of B and T cell cancers. "
05/14/1998 - "The association of LMP1 with TRAF-1 or TRAF-3 in tumor tissue was studied with double-immunofluorescence microscopy and immunoprecipitation assays. "
02/05/2015 - "To determine whether TRAF3 loss might be relevant to human NHL, we also analyzed 148 human diffuse large B-cell lymphoma (DLBCL) tumors and identified loss of TRAF3 as a common event, affecting ∼9% of DLBCLs, and reduced expression of TRAF3 among deleted cases. "
09/01/2015 - "Loss-of-function mutations in TRAF3 are associated with human B cell malignancies, in particular multiple myeloma. "
01/01/2014 - "Application of our pipeline to whole-genome MP and PE sequencing data from three multiple myeloma cell lines (KMS11, MM.1S, and RPMI8226) recovered known SVs, such as heterozygous TRAF3 deletion, as well as a novel experimentally validated SPI1 - ZNF287 inter-chromosomal rearrangement in the RPMI8226 cell line. "
01/01/2013 - "Furthermore, loss-of-function mutations of the traf3 gene have been associated with human B cell malignancies, especially multiple myeloma (MM). "
05/01/2011 - "Single nucleotide polymorphisms in the TRAF3 rs12147254 A allele and a specific haplotype 1 of TRAF3 [GAACAG] are associated with a decreased risk of multiple myeloma (odds ratio 0.709, P<0.001, and odds ratio 0.543, P<0.0001), while TRAF3 haplotype 4 [GGACAG] was associated with an increased risk of development of multiple myeloma (odds ratio 2.099, P=0.001). "
08/05/2008 - "Mutations leading to overexpression of NIK and deletion of the TRAF3 gene are implicated in human multiple myeloma. "
03/01/2014 - "The Sox5 expressed in TRAF3(-/-) B lymphomas represents a novel isoform of Sox5, and was localized in the nucleus of malignant B cells. "
01/01/2014 - "We used microarray analysis to identify genes differentially expressed in TRAF3-/- mouse splenic B lymphomas. "
04/01/2013 - "Given the high expression of RIP2 in the B lymphoma cell line and endogenous interaction between TRAF3 and RIP2 in Ramos cells, the role of RIP2 was further studied. "
05/01/2012 - "Specific deletion of TRAF3 in B lymphocytes leads to B-lymphoma development in mice."
12/15/2002 - "Coimmunoprecipitation experiments indicated that BAFF-R interacts with TRAF3 in B lymphoma cells and this interaction is stimulated by TALL-1 treatment. "
|4.||Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/01/2013 - "The aim of the present study is to explore the potential roles of TRAF3 and TRAF5 in patients with inflammatory bowel disease. "
01/01/2013 - "TRAF3 and TRAF5 are overexpressed in inflammatory bowel disease. "
01/01/2013 - "However, the expressions of TRAF3 and TRAF5 in patients with inflammatory bowel disease have not been elucidated. "
01/01/2013 - "Up-regulation and pre-activation of TRAF3 and TRAF5 in inflammatory bowel disease."
|5.||Spinal Cord Injuries (Spinal Cord Injury)
|1.||TNF Receptor-Associated Factor 5
|4.||N-benzyladriamycin-14-valerate (AD 198)
|5.||Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
|6.||TNF Receptor-Associated Factor 6 (TRAF6)
|7.||TNF Receptor-Associated Factor 3
|8.||NF-kappa B (NF-kB)
|10.||Small Interfering RNA (siRNA)